Xeroderma pigmentosum--biochemical and therapeutic aspects. Case report

Scand J Plast Reconstr Surg. 1977;11(2):173-7. doi: 10.3109/02844317709025515.

Abstract

Four patients with Xeroderma pigmentosum are reported: 2 diagnosed following the development of multiple cutaneous tumours, and 2 at an earlier state. The repair synthesis of DNA after ultraviolet radiation was reduced in 3 and normal in 1 patients. Para-aminobenzoic acid (PABA) was used topically as sunscreen; for those intolerant to PABA, alternatives are given. 5-fluoro-uracil had satisfactory effect against actinic keratoses. Two patients had associated neurologic and mental abnormalities compatible with deSanctis-Cacchione syndrome, a Xeroderma pigmentosum variant.

Publication types

  • Case Reports

MeSH terms

  • 4-Aminobenzoic Acid / administration & dosage
  • 4-Aminobenzoic Acid / therapeutic use*
  • Administration, Topical
  • Adult
  • Aminobenzoates / therapeutic use*
  • Child
  • DNA Repair / radiation effects
  • Female
  • Fluorouracil / therapeutic use*
  • Humans
  • Male
  • Photosensitivity Disorders
  • Sunscreening Agents / therapeutic use*
  • Ultraviolet Rays
  • Xeroderma Pigmentosum* / drug therapy
  • Xeroderma Pigmentosum* / metabolism

Substances

  • Aminobenzoates
  • Sunscreening Agents
  • 4-Aminobenzoic Acid
  • Fluorouracil